Terms: = Head and neck cancer AND FOXO3, FKHRL1, 2309, ENSG00000118689, MGC31925, MGC12739, FOXO2, FOXO3A, O43524, AF6q21, FKHRL1P2, DKFZp781A0677 AND Treatment
26 results:
1. Racial Disparities in head and neck cancer: It's Not Just About Access.
Whitehead RA; Patel EA; Liu JC; Bhayani MK
Otolaryngol Head Neck Surg; 2024 Apr; 170(4):1032-1044. PubMed ID: 38258967
[TBL] [Abstract] [Full Text] [Related]
2. RASSF1A promotes radiosensitivity in nasopharyngeal carcinoma by promoting foxo3a and inhibiting the Nrf2/TXNRD1 signaling pathway.
Si Y; Meng L; Zhang B; Wu Y; Du Q; Xu J; Qi J
Neoplasma; 2023 Oct; 70(5):633-644. PubMed ID: 38053374
[TBL] [Abstract] [Full Text] [Related]
3. Knockdown of LAMB3 suppressed radioresistance in nasopharyngeal carcinoma via deactivating NRF2 signaling pathway.
Zhuang Q; Liu G; Huang W; He Z
J Radiat Res; 2023 May; 64(3):509-519. PubMed ID: 36947579
[TBL] [Abstract] [Full Text] [Related]
4. HSF1 activates the foxo3a-ΔNp63α-CDK4 axis to promote head and neck squamous cell carcinoma cell proliferation and tumour growth.
Wang Y; Zhu Q; Guo S; Ao J; Zhang W; Fei J; Yu S; Niu M; Zhang Y; Sherman MY; Xiao ZJ; Yi Y
FEBS Lett; 2023 Apr; 597(8):1125-1137. PubMed ID: 36700826
[TBL] [Abstract] [Full Text] [Related]
5. Contribution of microRNA-30d to the prevention of the thyroid cancer occurrence and progression: mechanism and implications.
Li Y; He Y; Chen Y; He Z; Yang F; Xing C
Apoptosis; 2023 Apr; 28(3-4):576-593. PubMed ID: 36695983
[TBL] [Abstract] [Full Text] [Related]
6. SN-38, an active metabolite of irinotecan, enhances anti-PD-1 treatment efficacy in head and neck squamous cell carcinoma.
Lee YM; Chen YH; Ou DL; Hsu CL; Liu JH; Ko JY; Hu MC; Tan CT
J Pathol; 2023 Apr; 259(4):428-440. PubMed ID: 36641765
[TBL] [Abstract] [Full Text] [Related]
7. Irradiation-induced exosomal HMGB1 to confer radioresistance via the PI3K/AKT/foxo3A signaling pathway in ESCC.
Du X; Zhang X; Dong J; Zou N; Guo D; Yao W; Wang X; Li S; Song C; Yan K; Shen W; Zhu S
J Transl Med; 2022 Nov; 20(1):507. PubMed ID: 36335371
[TBL] [Abstract] [Full Text] [Related]
8. RBM47/SNHG5/foxo3 axis activates autophagy and inhibits cell proliferation in papillary thyroid carcinoma.
Qin Y; Sun W; Wang Z; Dong W; He L; Zhang T; Lv C; Zhang H
Cell Death Dis; 2022 Mar; 13(3):270. PubMed ID: 35338124
[TBL] [Abstract] [Full Text] [Related]
9. MiR-155 Inhibitor-Laden Exosomes Reverse Resistance to Cisplatin in a 3D Tumor Spheroid and Xenograft Model of Oral cancer.
Sayyed AA; Gondaliya P; Mali M; Pawar A; Bhat P; Khairnar A; Arya N; Kalia K
Mol Pharm; 2021 Aug; 18(8):3010-3025. PubMed ID: 34176265
[TBL] [Abstract] [Full Text] [Related]
10. Pitavastatin induces apoptosis in oral squamous cell carcinoma through activation of foxo3a.
Lee N; Tilija Pun N; Jang WJ; Bae JW; Jeong CH
J Cell Mol Med; 2020 Jun; 24(12):7055-7066. PubMed ID: 32406610
[TBL] [Abstract] [Full Text] [Related]
11. Role of foxo3A in Trastuzumab Combination Chemotherapy in Esophageal Squamous Cell Carcinoma.
Takahashi M; Fukuda K; Saikawa Y; Nakamura R; Wada N; Kawakubo H; Takeuchi H; Kitagawa Y
Anticancer Res; 2020 Apr; 40(4):1921-1930. PubMed ID: 32234881
[TBL] [Abstract] [Full Text] [Related]
12. Lapatinib sensitivity in nasopharyngeal carcinoma is modulated by SIRT2-mediated foxo3 deacetylation.
Aimjongjun S; Mahmud Z; Jiramongkol Y; Alasiri G; Yao S; Yagüe E; Janvilisri T; Lam EW
BMC Cancer; 2019 Nov; 19(1):1106. PubMed ID: 31727006
[TBL] [Abstract] [Full Text] [Related]
13. Down-regulation of miR-155 promotes apoptosis of nasopharyngeal carcinoma CNE-1 cells by targeting PI3K/AKT-foxo3a signaling.
Wu S; Xie DL; Dai XY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7391-7398. PubMed ID: 31539126
[TBL] [Abstract] [Full Text] [Related]
14. Dracorhodin perchlorate induces apoptosis and G2/M cell cycle arrest in human esophageal squamous cell carcinoma through inhibition of the JAK2/STAT3 and AKT/foxo3a pathways.
Lu Z; Lu C; Li C; Jiao Y; Li Y; Zhang G
Mol Med Rep; 2019 Sep; 20(3):2091-2100. PubMed ID: 31322237
[TBL] [Abstract] [Full Text] [Related]
15. RAC1 inhibition reverses cisplatin resistance in esophageal squamous cell carcinoma and induces downregulation of glycolytic enzymes.
Zeng RJ; Zheng CW; Gu JE; Zhang HX; Xie L; Xu LY; Li EM
Mol Oncol; 2019 Sep; 13(9):2010-2030. PubMed ID: 31314174
[TBL] [Abstract] [Full Text] [Related]
16. Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.
Salem ME; Puccini A; Xiu J; Raghavan D; Lenz HJ; Korn WM; Shields AF; Philip PA; Marshall JL; Goldberg RM
Oncologist; 2018 Nov; 23(11):1319-1327. PubMed ID: 29866946
[TBL] [Abstract] [Full Text] [Related]
17. Symptomatic Relief is Related to Serum Free Triiodothyronine Concentrations during Follow-up in Levothyroxine-Treated Patients with Differentiated Thyroid cancer.
Larisch R; Midgley JEM; Dietrich JW; Hoermann R
Exp Clin Endocrinol Diabetes; 2018 Sep; 126(9):546-552. PubMed ID: 29396968
[TBL] [Abstract] [Full Text] [Related]
18. Biochemical changes of salivary gland adenoid cystic carcinoma cells induced by SGI-1776.
Hou X; Yu Y; Feng J; Wang J; Zheng C; Ling Z; Ge M; Zhu X
Exp Cell Res; 2017 Mar; 352(2):403-411. PubMed ID: 28228352
[TBL] [Abstract] [Full Text] [Related]
19. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
[TBL] [Abstract] [Full Text] [Related]
20. STRESS-responsive deacetylase SIRT3 is up-regulated by areca nut extract-induced oxidative stress in human oral keratinocytes.
Chen IC; Chiang WF; Chen PF; Chiang HC
J Cell Biochem; 2014 Feb; 115(2):328-39. PubMed ID: 24339251
[TBL] [Abstract] [Full Text] [Related]
[Next]